Are PPAR alpha agonists a rational therapeutic strategy for preventing abnormalities of the diabetic kidney?

Are PPAR alpha agonists a rational therapeutic strategy for preventing abnormalities of the diabetic kidney?

Item
http://www.wikidata.org/entity/Q37979621
Clinical therapeutic strategies for early stage of diabetic kidney disease.Anthocyanins inhibit high-glucose-induced cholesterol accumulation and inflammation by activating LXRα pathway in HK-2 cellsNew Insights into the PPAR γ Agonists for the Treatment of Diabetic Nephropathy.Fenofibrate and the kidney: an overview.Refocusing Peroxisome Proliferator Activated Receptor-α: A New Insight for Therapeutic Roles in Diabetes.Less known pathophysiological mechanisms of anemia in patients with diabetic nephropathy.Effect of edaravone in diabetes mellitus-induced nephropathy in rats.Interaction of PPARα With the Canonic Wnt Pathway in the Regulation of Renal Fibrosis.Protective effect of peroxisome proliferator activator receptor (PPAR)-α and -γ ligands against methotrexate-induced nephrotoxicity.Delayed treatment with fenofibrate protects against high-fat diet-induced kidney injury in mice: the possible role of AMPK autophagy.Total flavones of Abelmoschus manihot improve diabetic nephropathy by inhibiting the iRhom2/TACE signalling pathway activity in rats.Resveratrol, an Nrf2 activator, ameliorates aging-related progressive renal injury.Chronic oral administration of low-dose combination of fenofibrate and rosuvastatin protects the rat heart against experimentally induced acute myocardial infarction.
P2860

Are PPAR alpha agonists a rational therapeutic strategy for preventing abnormalities of the diabetic kidney?

Item
http://www.wikidata.org/entity/Q37979621
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Are PPAR alpha agonists a rati ...... lities of the diabetic kidney?
@en
Are PPAR alpha agonists a rati ...... lities of the diabetic kidney?
@nl
type
label
Are PPAR alpha agonists a rati ...... lities of the diabetic kidney?
@en
Are PPAR alpha agonists a rati ...... lities of the diabetic kidney?
@nl
prefLabel
Are PPAR alpha agonists a rati ...... lities of the diabetic kidney?
@en
Are PPAR alpha agonists a rati ...... lities of the diabetic kidney?
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Are PPAR alpha agonists a rati ...... lities of the diabetic kidney?
@en
P2093
P304
P31
P356
10.1016/J.PHRS.2012.01.004
P433
P478
P50
P577
P698